InvestorsHub Logo
Followers 0
Posts 287
Boards Moderated 1
Alias Born 08/29/2010

Re: None

Monday, 08/30/2010 8:55:05 AM

Monday, August 30, 2010 8:55:05 AM

Post# of 7574
Given that Diabetes is the sixth leading cause of death in the US, Spencer Pharmaceutical is well positioned to address the growth of this market with its proprietary "controlled release" technology. The global diabetes market was worth$18.6bn in 2005, which was an 11.5% increase from 2004 sales of $16.6bn.